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Two recent studies identify how sex-specific pheromonal factors in flies and worms alter lifespan
through metabolic pathways that are shared with mammals. Sex differences in human lifespans
imply nonautonomous effectsmodulated by sex-specific gene-environment interactions that could
still include pheromonal mechanisms.Two studies in Science from Maures et al.
and Gendron et al. reporting on short-
lived flies and worms elegantly document
the social-environmental modulation of
aging and longevity (Gendron et al.,
2013; Maures et al., 2013). For both flies
and worms, the authors found that life-
span was shortened by the opposite sex
through pheromones, or diffusible agents,
that modulate insulin-like signaling and
other metabolic axes. Specific sensory
neurons were defined for each species
to mediate these nonautonomous aging
processes. The ‘‘male-induced demise’’
(MID) of hermaphrodite worms was
confirmed for two species of Caenorhab-
ditis that diverged more than 20 million
years ago.
Although the role of diffusible sex-spe-
cific agents on reproduction is a plausible
targetofnatural selection, acaveat on their
application to aging is that lab animal life-
spans are much longer for these species
than in the Darwinian world. But don’t
throw the baby out with the bathwater.
Our favorite lab species are authentic
models for most humans of developed
economies who enjoy relatively protected
lives withminimal mortality from predation
and infection and from ad libitum food.
Moreover, we may find insights about
modern aging from gene-environment in-
teractions (G3E) of alleles that were
selected for resistance to seasonal/spo-
radic nutrient shortages and infections,
which caused >80% of death throughout
life until recently. Thus, the aging of lab
models and modern humans may be
considered in a post-Darwinian context.
Mammals also share pheromonal
effects on reproduction, including the398 Cell 156, January 30, 2014 ª2014 Elseviewell-known synchrony of ovulatory cycles
in co-domiciling young women and the
tendency of mice to miscarry when
co-housed with a male that is not the
father (Hoskison, 2013). Although phero-
monal effects on longevity are not yet
known for mammals, pheromonal recog-
nition of the opposite sex could be a
mediator of the social interactions of
humans that can influence mortality at
later ages. A literature not reviewed here
documents that the strength of social
support significantly influences the risk
of and survival of heart attack, cancer,
and hip fracture.
Our biological sex is a major factor in
environmental influences on aging and
the lifespan, which for women now ex-
ceeds mens’ throughout the world. Since
1800, human longevity has progressively
increased as the result of improving envi-
ronment and medicine. Moreover, since
1900, sex differences have emerged, in
which the lifespan has increased more
for women: by 90, the female:male ratio
is 1.7 and by 100 has climbed to 3:1.
Thus, our youngest generation is much
more likely to personally know their
great-grandmoms than their great-grand-
dads. The puzzle of why women have
benefitted most from the improving envi-
ronment and medicine of the past century
leads us to consider sex effects on gene-
by-environment interactions during aging.
There are striking sex differences in
morbidity and mortality, e.g., a 50%
excess of mortality from heart attack
in men (Lawlor et al., 2001). Unfor-
tunately, resolution of possible underlying
‘‘intrinsic’’ sex differences in heart dis-
ease is confounded by smoking, diet,r Inc.and other lifestyle differences that influ-
ence atherosclerosis. Fortunately, rodent
models provide the benefit of little athero-
sclerosis during aging. However, few
studies have examined sex differences
in vitro in mammalian cells. As a model
for ischemia, cardiomyocytes in vitro
(Ross and Howlett 2012) were more resis-
tant to hypoxia in female-derived cells.
There is an emerging literature of in vitro
analyses of sex differences, e.g., aneu-
rysms (Wang et al., 2010) and arterial
vasoresponses (Zhang et al., 2012).
Sex chromosome differences are
emerging as a contributor to aging across
species. A recent British study of the Y
chromosome found haplotypes for coro-
nary artery disease (CAD) risk in the
male-specific region (MSY) that were
independent of traditional CAD and socio-
economic risk factors (Charchar et al.,
2012). More broadly, sex-specific selec-
tive pressures are hypothesized to
maintain deleterious gene alleles in the
population that contribute to aging and
disease (sexual antagonistic pleiotropy
[SAP]) (Tower 2010). Therefore, chromo-
somal sex and sexual differentiation may
be epistatic to the lifespan-shortening
effects of many genes. Analyses of gene
expression patterns and of mitochondrial
function during aging suggest trade-offs
between mitochondrial biogenesis versus
growth, sexual differentiation, and repro-
duction, which leads to mitochondrial
dysfunction during aging and the associ-
ated inflammation and proteotoxicity
(Shen and Tower, 2013).
Although the lifespan-shortening effects
of the fly and worm pheromones were
made clear in these reports, possible
Figure 1. Gene-by-Environment-by-Sex Interactions for p53
The change in lifespan caused by dominant p53 mutations (p53M/p53M
genotype) relative to wild-type (+/+ genotype) for male (M) and female (F) flies
under two different environmental conditions. Data and details of genotypes
and environments are as described (Waskar et al., 2009).benefits to reproduction were
not described. These phero-
mones may also have actions
similar to the well-known fly
sex peptide of seminal fluid
(cited in Maures et al., 2013).
Sex peptide exhibits SAP by
dual actions of shortening the
lifespan and increasing egg
production of inseminated
females. Sex peptide acts, in
part, through neurons ex-
pressing the sexual differenti-
ation gene fruitless. Similarly,
the female fly pheromone
described in Gendron et al.,
2013acts through fruitless-ex-
pressing neurons in the male
and causes gene expression
changes shared across both
sexual differentiation and ag-ing (Gendron et al., 2013). Lastly, we note
that the worm MID acts through insulin-
like signaling—a conserved pathway that
is known topromoteboth sexual differenti-
ation and aging.
The p53 gene, famed as a tumor sup-
pressor and mitochondrial regulator,
may be an archetypical example of a
conserved gene exhibiting SAP (Waskar
et al., 2009; Tower 2010). In flies, p53
shortens lifespan more in females than in
males, and p53 mutations often have
opposite sex-specific effects that are
dependent upon the environment
(Figure 1). In part, the sex dimorphism in
p53 effects on fly lifespan are dependent
upon foxo gene activity, which is a
conserved target of insulin-like signaling.
In humans, p53 also appears to be more
active in females. Women normally have
a lower incidence of cancer during agingthan men, and inherited p53 mutations
cause 7-fold more cancer in women than
in men. Moreover, segregating alleles of
both p53 and the p53 regulatory gene
MDM2 are associated with sex-dimorphic
cancer and lifespan (Di Pietro et al., 2013,
and references therein). Taken together,
the data support an aging mechanism in
which conserved pathways including
insulin-like signaling promote sexual dif-
ferentiation and the SAP of genes such
as p53 and foxo (Tower 2010). We antici-
pate major findings in the molecular
biology of sex-specific G3E interactions
in human aging and disease.ACKNOWLEDGMENTS
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